Associated Papers
Retinal Pigment Epithelium-Targeting Gene Therapy Corrects Ocular Symptoms in Mouse and Rat Models of Oculocutaneous Albinism Type I.
Song L et al.
Medcomm, 2025
Albino mice with the point mutation at the tyrosinase locus show high cholesterol diet-induced NASH susceptibility.
Kulathunga K et al.
Scientific Reports, 2021
Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.
Dolinska MB et al.
Pigment Cell & Melanoma Research, 2017
Novel Hypomorphic Alleles of the Mouse Tyrosinase Gene Induced by CRISPR-Cas9 Nucleases Cause Non-Albino Pigmentation Phenotypes.
Challa AK et al.
Plos One, 2016
Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.
Onojafe IF et al.
The Journal of Clinical Investigation, 2011
Genetic analyses of fancy rat-derived mutations.
Kuramoto T et al.
Experimental Animals, 2010
Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma.
Anderson MG et al.
Bmc Biology, 2006
The Tyr (albino) locus of the laboratory mouse.
Beermann F et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society, 2004
Select a paper to view details